АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

CONCLUSION

A great deal of progress has been made in the pharmacological treatment of ED. In the past, the most effective therapy required intracavernosal injections, but an increasing number of oral agents have been introduced with very good success rates. Any successful pharmacological treatment for erectile failure demands a degree of integrity of the penile mechanisms of erection. Further studies of individual agents and synergistic activity of available substances are underway. The search for the ideal pharmacological therapy for erectile failure aims at fulfilling the following characteristics: good efficacy, easy administration, freedom from toxicity and side-effects, with a rapid onset and a possible long-acting effect.

REFERENCES

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB.

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. JUrol 1994; 151: 54-61.

Lue TF, Tanagho EA.

Physiology of erection and pharmacologic management of impotence. J Urol 1987; 137: 829.

3. Krane RJ, Goldstein I, Saenz De Tejada I.

Medical progress: impotence. N Engl J Med 1989; 321: 1648-1653.

Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA.

Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-1404.

Дата добавления: 2015-09-18 | Просмотры: 442 | Нарушение авторских прав